A detailed history of Mai Capital Management transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Mai Capital Management holds 16,737 shares of SERA stock, worth $113,811. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,737
Previous 16,737 -0.0%
Holding current value
$113,811
Previous $99,000 31.31%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$1.65 - $6.85 $415 - $1,726
-252 Reduced 1.48%
16,737 $100,000
Q2 2023

Aug 02, 2023

SELL
$3.0 - $3.98 $9,033 - $11,983
-3,011 Reduced 15.06%
16,989 $55,000
Q4 2022

Feb 09, 2023

SELL
$1.16 - $1.8 $34,223 - $53,105
-29,503 Reduced 59.6%
20,000 $25,000
Q3 2022

Nov 15, 2022

BUY
$1.55 - $2.71 $76,729 - $134,153
49,503 New
49,503 $79,000

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $201M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Mai Capital Management Portfolio

Follow Mai Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.